Skip to main content
Sign In

University of Colorado Cancer Center

University of Colorado Cancer Center, A National Cancer Institute-designated Comprehensive Cancer Center

Bolin Liu, MD



Breast Cancer Biology


University of Colorado Anschutz Medical Campus


Must have completed one year of college

Number of Openings:  1-2


With the focus on the unique biological features of ErbB3 receptor in ErbB2-mediated breast cancer formation and progression, we hope to identify novel therapeutic agents for breast cancer patients with ErbB2-overexpressing tumors.


The student will gain basic knowledge of ErbB receptor signaling transduction pathways, learn cell culture techniques, cell proliferation assays, western blot analysis of protein expression and activation, evaluate therapeutic agents-induced apoptosis with ELISA, and explore the synergistic inhibitory effects of drug combinations on breast cancer cells.


© The Regents of the University of Colorado, a body corporate. All rights reserved.

Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.